AHI-1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-AHI-1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityAHI-1
Clonemonoclonal
Host SpeciesMouse
Reactive SpeciesIt only reacts with murine Ahi-1 but not human AHI-1 protein. We have not tested if it also reacts with other species of Ahi-1.
IsotypeIgG1
Formataffinity purified
Size0.1 mg
Concentration100ug/100ul
ApplicationsWestern Blot (WB), IPP, Immunohistochemsitry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: It only specifically reacts with murine Ahi-1. Abelson helper integration site-1 (Ahi-1) is a novel oncogene identified based on its common activation in v-abl and myc-induced murine lymphomas. The murine Ahi-1 gene encodes a unique protein with multiple SH3 binding sites, an SH3 domain and multiple WD40-repeat domains. The conserved human homolog (AHI-1) contains an additional coiled-coil domain in its N-terminal region. Both murine and human Ahi-1/AHI-1 genes encode at least three isoforms and thus this gene is also subject to alternative splicing in normal cells. Expression of Ahi-1/AHI-1 is regulated at multiple stages of hematopoiesis in a highly conserved fashion in mouse and humans. It is highly elevated in certain human
ImmunogenImmunogen: C-mAhi-1 M5 reacts with an epitope in the c-terminal region of mouse Ahi-1 protein. A recombinant mouse Ahi-1 GST fusion protein was used as immunogen. This antibody was purified from supernatant by affinity chromatography.
Other Names[C-mAhi-1 M5], [AHI-1]
Gene, Accession #[AHI-1], NCBI: AAM94177.1
Catalog #MBS415348
Price$260
Order / More InfoAHI-1 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesChen, M et al. Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J. Natl. Cancer Inst. 105:405-23 (2013). PubMed: 23446755.Liu, X et al. Molecular and structural characterization of the SH3 domain of AHI-1 in regulation of cellular resistance of BCR-ABL( ) chronic myeloid leukemia cells to tyrosine kinase inhibitors. Proteomics 12:2094-106 (2012). PubMed: 22623184.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.